Episode Details
Back to Episodes
42_Watch Out. Europe Is Gaining Ground Over The U.S. In Cannabis Medicine
Description
Michael Sassano, CEO of Somai Pharmaceuticals, a European pharmaceutical, and biotech company centered on manufacturing in Lisbon, Portugal says the data is clear. The US may have more research funds, but they are stymied by the lack of legalization and Europe is about to take the lead on testing and clinical trials.
Michael is one of the most respected executives in the pharmaceutical cannabis space today. And he is celebrated in mainstream business and biopharma media as an international authority on developing large-scale cannabis infrastructures throughout the world and the most advanced pharmaceutical cannabinoid products.
He is also widely respected for successfully predicting long term cannabis market trends and movements, which he generously shares in many forums.
https://www.somaipharma.eu/
https://www.linkedin.com/in/michaelsassano3/
The Innovating Cannabis podcast is produced and hosted by Pam Chmiel, a freelance writer and editor for the Cannabis Industry Journal.
Get in touch with pam@InnovatingCannabisPodcast.com.
Please like the show to help us reach more listeners🙏🏻
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.